0001387131-19-005129.txt : 20190716 0001387131-19-005129.hdr.sgml : 20190716 20190716203339 ACCESSION NUMBER: 0001387131-19-005129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190712 FILED AS OF DATE: 20190716 DATE AS OF CHANGE: 20190716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN DOV A MD CENTRAL INDEX KEY: 0001120478 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35963 FILM NUMBER: 19958105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuBase Therapeutics, Inc. CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465622433 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 700 TECHNOLOGY DRIVE CITY: PITTSBURGH STATE: PA ZIP: 15219 BUSINESS PHONE: 6464501790 MAIL ADDRESS: STREET 1: 700 TECHNOLOGY DRIVE CITY: PITTSBURGH STATE: PA ZIP: 15219 FORMER COMPANY: FORMER CONFORMED NAME: Ohr Pharmaceutical Inc DATE OF NAME CHANGE: 20090819 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2019-07-12 0 0001173281 NeuBase Therapeutics, Inc. NBSE 0001120478 GOLDSTEIN DOV A MD C/O 700 TECHNOLOGY DRIVE, THIRD FLOOR PITTSBURGH PA 15219 1 0 0 0 Stock option (right to buy) 5.39 2019-07-12 4 A 0 227330 0 A 2029-07-12 Common stock 227330 227330 D 1/36th of the total shares subject to the option shall vest monthly over three years. /s/ Sam Backenroth, as attorney-in-fact for Dov A. Goldstein 2019-07-16